Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Org Chem ; 85(22): 14610-14618, 2020 Nov 20.
Article in English | MEDLINE | ID: mdl-32967420

ABSTRACT

A dynamic covalent chemistry approach was used for the stereoselective synthesis of 1,10-diaza-3,8,12,17-tetraphosphacyclooctadecanes via condensation reaction of 1,4-bis(organylphosphino)butane, formaldehyde, and primary amines. The obtained 18-membered P4N2 macrocycles were isolated in pure form as meso- (RPSPSPRP) or rac- (RPRPRPRP/SPSPSPSP) isomers. The structural features of the individual stereoisomers were revealed by NMR spectroscopy and X-ray structure analysis. All P4N2 macrocycles form square-planar nickel(II) complexes with the RPSPSPRP isomer only, in which the orientation of the lone pairs of electrons at phosphorus favors this coordination mode, independent of the initial configuration of the ligand, indicating the ability of the 18-membered P4N2 macrocycles to stereoisomerize in the course of the complexation.

2.
J Infect Dis ; 196 Suppl 2: S184-92, 2007 Nov 15.
Article in English | MEDLINE | ID: mdl-17940948

ABSTRACT

Ebola virus (EBOV) has caused outbreaks of severe viral hemorrhagic fever in regions of Central Africa where medical facilities are ill equipped and diagnostic capabilities are limited. To obtain a reliable test that can be implemented easily under these conditions, monoclonal antibodies to the EBOV matrix protein (VP40), which previously had been found to work in a conventional enzyme-linked immunosorbent assay, were used to develop an immunofiltration assay for the detection of EBOV antigen in chemically inactivated clinical specimens. The assay was evaluated by use of defined virus stocks and specimens from experimentally infected animals. Its field application was tested during an outbreak of Ebola hemorrhagic fever in 2003. Although the original goal was to develop an assay that would detect all EBOV species, only the Zaire and Sudan species were detected in practice. The assay represents a first-generation rapid field test for the detection of EBOV antigen that can be performed in 30 min without electrical power or expensive or sensitive equipment.


Subject(s)
Antigens, Viral/analysis , Hemorrhagic Fever, Ebola/diagnosis , Hemorrhagic Fever, Ebola/immunology , Adolescent , Adult , Antibodies, Monoclonal , Child , Democratic Republic of the Congo/epidemiology , Disease Outbreaks , Female , Hemorrhagic Fever, Ebola/epidemiology , Humans , Infant , Male , Reproducibility of Results
3.
Proc Natl Acad Sci U S A ; 104(43): 17123-7, 2007 Oct 23.
Article in English | MEDLINE | ID: mdl-17942693

ABSTRACT

Over the last 30 years, Zaire ebolavirus (ZEBOV), a virus highly pathogenic for humans and wild apes, has emerged repeatedly in Central Africa. Thus far, only a few virus isolates have been characterized genetically, all belonging to a single genetic lineage and originating exclusively from infected human patients. Here, we describe the first ZEBOV sequences isolated from great ape carcasses in the Gabon/Congo region that belong to a previously unrecognized genetic lineage. According to our estimates, this lineage, which we also encountered in the two most recent human outbreaks in the Republic of the Congo in 2003 and 2005, diverged from the previously known viruses around the time of the first documented human outbreak in 1976. These results suggest that virus spillover from the reservoir has occurred more than once, as predicted by the multiple emergence hypothesis. However, the young age of both ZEBOV lineages and the spatial and temporal sequence of outbreaks remain at odds with the idea that the virus simply emerged from a long-established and widespread reservoir population. Based on data from two ZEBOV genes, we also demonstrate, within the family Filoviridae, recombination between the two lineages. According to our estimates, this event took place between 1996 and 2001 and gave rise to a group of recombinant viruses that were responsible for a series of outbreaks in 2001-2003. The potential for recombination adds an additional level of complexity to unraveling and potentially controlling the emergence of ZEBOV in humans and wildlife species.


Subject(s)
Animals, Wild/virology , Ebolavirus/genetics , Ebolavirus/isolation & purification , Hominidae/virology , Recombination, Genetic , Animals , Ape Diseases/virology , Base Sequence , Congo/epidemiology , Democratic Republic of the Congo , Disease Outbreaks , Genes, Viral , Geography , Hemorrhagic Fever, Ebola/epidemiology , Hemorrhagic Fever, Ebola/veterinary , Humans , Molecular Sequence Data , Phylogeny , Time Factors
4.
Microbes Infect ; 7(7-8): 1005-14, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16002313

ABSTRACT

Several countries spanning the equatorial forest regions of Africa have had outbreaks of Ebola hemorrhagic fever over the last three decades. This article is an overview of the many published investigations of how Ebola virus circulates in its natural environment, focusing on the viral reservoir, susceptible animal species, environmental conditions favoring inter-species transmission, and how the infection is transmitted to humans. Major breakthroughs have been made in recent years but many outstanding questions must be dealt with if we are to prevent human outbreaks by interfering with the viral life cycle.


Subject(s)
Hemorrhagic Fever, Ebola/epidemiology , Hemorrhagic Fever, Ebola/virology , Africa/epidemiology , Animals , Disease Outbreaks , Disease Reservoirs , Hemorrhagic Fever, Ebola/transmission , Humans , Marburg Virus Disease/epidemiology
5.
J Endotoxin Res ; 9(4): 237-43, 2003.
Article in English | MEDLINE | ID: mdl-12935354

ABSTRACT

Bacterial DNA containing unmethylated CpG dinucleotides (CpG DNA) is a potent immune stimulating agent that holds strong promise in the treatment of many disorders. Studies have established that CpG DNA triggers an immune response through activated expression of genes in immune cells including macrophages. To dissect further the molecular mechanism(s) by which CpG DNA activates the immune system, we studied macrophage gene expression profiles in response to CpG DNA using microarray technology. Since CpG DNA is reported to use the TLR9 receptor that shares homology with the TLR4 receptor used by bacterial lipopolysaccharide (LPS), we also evaluated gene expression profiles in macrophages stimulated by LPS versus CpG DNA. Both CpG DNA and LPS modulate expression of a large array of genes. However, LPS modulated the expression of a much greater number of genes than did CpG DNA and all genes induced or repressed by CpG DNA were also induced or repressed by LPS. These data indicate that the CpG DNA signaling pathway through TLR9 activates only a subset of genes induced by the LPS TLR4 signaling pathway.


Subject(s)
DNA, Bacterial/pharmacology , Escherichia coli , Gene Expression Regulation/drug effects , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Animals , Cell Line , DNA-Binding Proteins/metabolism , Escherichia coli/chemistry , Gene Expression Profiling , Macrophages/metabolism , Mice , Receptors, Cell Surface/metabolism , Signal Transduction , Toll-Like Receptor 9
6.
J Leukoc Biol ; 72(6): 1234-45, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12488506

ABSTRACT

CpG-DNA is known as a potent immunostimulating agent and may contribute in therapeutic treatment of many immune disorders. CpG-DNA triggers innate and acquired immune responses through activated expression of various genes in immune cells, including macrophages. To define the molecular mechanism(s) by which CpG-DNA activates immune cells, we studied macrophage gene expression following CpG-DNA exposure using high-density oligonucleotide microarrays. As CpG-DNA receptor Toll-like receptor 9 (TLR9) shares homology with the lipopolysaccharide (LPS)-TLR4 receptor, we compared gene expression profiles in macrophages stimulated by LPS versus CpG-DNA. CpG-DNA and LPS modulate expression of many genes encoding cytokines, cell surface receptors, transcription factors, and proteins related to cell proliferation/differentiation. However, LPS modulated expression of significantly more genes than did CpG-DNA, and all genes induced or repressed by CpG-DNA were induced or repressed by LPS. We conclude that CpG-DNA signaling through TLR9 activates a subset of genes induced by LPS-TLR4 signaling.


Subject(s)
DNA, Bacterial/pharmacology , Gene Expression Regulation , Macrophages/metabolism , Oligodeoxyribonucleotides/pharmacology , Animals , Cell Line , DNA-Binding Proteins/physiology , Gene Expression Profiling , Macrophages/drug effects , Mice , Receptors, Cell Surface/physiology , Signal Transduction , Toll-Like Receptor 9
SELECTION OF CITATIONS
SEARCH DETAIL
...